http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2253264-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-0208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-37
filingDate 2000-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4d9299c1ec2db65e1d51e923e016d9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68585b1660fd79bc9db2960abe5bd25b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_446af909f0a8b6ebd9688d1d7bd2bc3c
publicationDate 2006-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2253264-T3
titleOfInvention THERAPEUTIC SURFACE SYSTEM FOR THE TOPICAL ADMINISTRATION OF ACETILSALICILIC ACID, FOR THE TREATMENT OF ACNE AND RELATED DISEASES.
abstract Use of acetylsalicylic acid for the manufacture of a surface administration system with a top layer impermeable to the active principle and to moisture, one or more matrix layers containing active principle and a removable protective layer, in which the active principle acetylsalicylic acid is at least in one of the matrix layers of the surface administration system partially in solid form as a suspension and partially in dilute form, and the proportion of acetylsalicylic acid present in solid form, based on the total mass of the acetylsalicylic acid contained in the system, is at minus 30%, for the treatment of acne and / or similar skin diseases by topical administration of acetylsalicylic acid.
priorityDate 1999-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426071153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416167085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420224962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407124392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454570259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21414
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414863358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456126543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448186583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421328696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86576271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2754342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID235850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415755887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7187

Total number of triples: 73.